Drugs / MMRV
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00847145 Background | Feb 2009 → Aug 2010 | meningococcal infection | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MMRV | “These subjects received a booster (fourth) dose at 12 months and one dose of MMRV vaccine at 13 months of age in the present study.” NCT00847145 ↗ |
| Modality | Vaccine | “one dose of MMRV vaccine at 13 months of age in the present study.” NCT00847145 ↗ |